vs
Side-by-side financial comparison of Mama's Creations, Inc. (MAMA) and Sanara MedTech Inc. (SMTI). Click either name above to swap in a different company.
Mama's Creations, Inc. is the larger business by last-quarter revenue ($47.3M vs $27.5M, roughly 1.7× Sanara MedTech Inc.). Mama's Creations, Inc. runs the higher net margin — 1.1% vs -5.9%, a 7.0% gap on every dollar of revenue. On growth, Mama's Creations, Inc. posted the faster year-over-year revenue change (50.0% vs 4.6%). Sanara MedTech Inc. produced more free cash flow last quarter ($3.9M vs $3.7M). Over the past eight quarters, Mama's Creations, Inc.'s revenue compounded faster (33.0% CAGR vs 21.8%).
Mama's Creations, Inc. is a U.S.-based food manufacturing enterprise that produces a wide portfolio of refrigerated ready-to-eat and heat-and-serve food products, including Italian-style meatballs, sausages, pasta dishes, and other prepared meals. It mainly distributes its offerings to grocery retailers, mass merchandisers and foodservice partners across the United States, focusing on convenient, high-quality comfort food for daily consumer demand.
Sanara MedTech Inc. is a US-based medical technology company that develops, manufactures, and distributes innovative surgical, wound care, and post-acute rehabilitation products. It mainly serves healthcare providers, hospitals, and long-term care facilities across North America, with a portfolio of FDA-cleared solutions designed to improve patient outcomes and lower clinical care operational costs.
MAMA vs SMTI — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.3M | $27.5M |
| Net Profit | $540.0K | $-1.6M |
| Gross Margin | 23.6% | 93.2% |
| Operating Margin | 1.7% | 23.5% |
| Net Margin | 1.1% | -5.9% |
| Revenue YoY | 50.0% | 4.6% |
| Net Profit YoY | 31.7% | 5.3% |
| EPS (diluted) | $0.01 | $-0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.3M | $27.5M | ||
| Q3 25 | $35.2M | $26.3M | ||
| Q2 25 | $35.3M | $25.8M | ||
| Q1 25 | $33.6M | $23.4M | ||
| Q4 24 | $31.5M | $26.3M | ||
| Q3 24 | $28.4M | $21.7M | ||
| Q2 24 | $29.8M | $20.2M | ||
| Q1 24 | $26.7M | $18.5M |
| Q4 25 | $540.0K | $-1.6M | ||
| Q3 25 | $1.3M | $-30.4M | ||
| Q2 25 | $1.2M | $-2.0M | ||
| Q1 25 | $1.6M | $-3.5M | ||
| Q4 24 | $410.0K | $-1.7M | ||
| Q3 24 | $1.1M | $-2.9M | ||
| Q2 24 | $553.0K | $-3.5M | ||
| Q1 24 | $1.4M | $-1.8M |
| Q4 25 | 23.6% | 93.2% | ||
| Q3 25 | 24.9% | 92.9% | ||
| Q2 25 | 26.1% | 92.5% | ||
| Q1 25 | 27.0% | 92.2% | ||
| Q4 24 | 22.6% | 91.4% | ||
| Q3 24 | 24.2% | 90.8% | ||
| Q2 24 | 25.0% | 90.0% | ||
| Q1 24 | 29.3% | 89.8% |
| Q4 25 | 1.7% | 23.5% | ||
| Q3 25 | 4.8% | 11.2% | ||
| Q2 25 | 4.5% | -0.1% | ||
| Q1 25 | 5.7% | -8.9% | ||
| Q4 24 | 1.8% | 18.6% | ||
| Q3 24 | 5.7% | 3.6% | ||
| Q2 24 | 2.6% | -14.3% | ||
| Q1 24 | 7.4% | -8.3% |
| Q4 25 | 1.1% | -5.9% | ||
| Q3 25 | 3.6% | -115.5% | ||
| Q2 25 | 3.5% | -7.8% | ||
| Q1 25 | 4.8% | -15.1% | ||
| Q4 24 | 1.3% | -6.5% | ||
| Q3 24 | 4.0% | -13.2% | ||
| Q2 24 | 1.9% | -17.4% | ||
| Q1 24 | 5.3% | -9.5% |
| Q4 25 | $0.01 | $-0.32 | ||
| Q3 25 | $0.03 | $-3.40 | ||
| Q2 25 | $0.03 | $-0.23 | ||
| Q1 25 | $0.04 | $-0.41 | ||
| Q4 24 | $0.01 | $-0.18 | ||
| Q3 24 | $0.03 | $-0.34 | ||
| Q2 24 | $0.01 | $-0.41 | ||
| Q1 24 | $0.03 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.1M | $16.6M |
| Total DebtLower is stronger | — | $46.0M |
| Stockholders' EquityBook value | $49.6M | $5.9M |
| Total Assets | $84.0M | $72.9M |
| Debt / EquityLower = less leverage | — | 7.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.1M | $16.6M | ||
| Q3 25 | $9.4M | $14.9M | ||
| Q2 25 | $12.0M | $17.0M | ||
| Q1 25 | $7.2M | $20.7M | ||
| Q4 24 | $9.3M | $15.9M | ||
| Q3 24 | $7.4M | $16.3M | ||
| Q2 24 | $13.0M | $6.2M | ||
| Q1 24 | $11.0M | $2.8M |
| Q4 25 | — | $46.0M | ||
| Q3 25 | — | $45.1M | ||
| Q2 25 | — | $44.2M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $30.7M | ||
| Q3 24 | — | $30.1M | ||
| Q2 24 | — | $14.4M | ||
| Q1 24 | — | $9.7M |
| Q4 25 | $49.6M | $5.9M | ||
| Q3 25 | $29.6M | $6.1M | ||
| Q2 25 | $26.4M | $35.4M | ||
| Q1 25 | $24.9M | $36.7M | ||
| Q4 24 | $23.0M | $39.4M | ||
| Q3 24 | $22.3M | $39.8M | ||
| Q2 24 | $20.3M | $41.7M | ||
| Q1 24 | $19.6M | $43.3M |
| Q4 25 | $84.0M | $72.9M | ||
| Q3 25 | $51.2M | $71.1M | ||
| Q2 25 | $52.7M | $98.8M | ||
| Q1 25 | $47.1M | $96.4M | ||
| Q4 24 | $47.9M | $88.1M | ||
| Q3 24 | $43.0M | $88.5M | ||
| Q2 24 | $47.2M | $73.4M | ||
| Q1 24 | $45.1M | $70.9M |
| Q4 25 | — | 7.74× | ||
| Q3 25 | — | 7.33× | ||
| Q2 25 | — | 1.25× | ||
| Q1 25 | — | 1.18× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | 0.76× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.9M | $3.9M |
| Free Cash FlowOCF − Capex | $3.7M | $3.9M |
| FCF MarginFCF / Revenue | 7.8% | 14.0% |
| Capex IntensityCapex / Revenue | 0.4% | 0.3% |
| Cash ConversionOCF / Net Profit | 7.16× | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.0M | $2.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.9M | $3.9M | ||
| Q3 25 | $-1.7M | $2.2M | ||
| Q2 25 | $6.0M | $2.7M | ||
| Q1 25 | $-857.0K | $-2.0M | ||
| Q4 24 | $4.8M | $932.0K | ||
| Q3 24 | $-2.4M | $2.1M | ||
| Q2 24 | $3.6M | $-1.4M | ||
| Q1 24 | $6.7M | $-1.6M |
| Q4 25 | $3.7M | $3.9M | ||
| Q3 25 | $-2.2M | $1.1M | ||
| Q2 25 | $5.5M | $902.7K | ||
| Q1 25 | $-930.0K | $-3.7M | ||
| Q4 24 | $2.5M | $859.9K | ||
| Q3 24 | $-4.0M | $2.0M | ||
| Q2 24 | $2.5M | $-1.5M | ||
| Q1 24 | $6.6M | $-1.7M |
| Q4 25 | 7.8% | 14.0% | ||
| Q3 25 | -6.2% | 4.2% | ||
| Q2 25 | 15.5% | 3.5% | ||
| Q1 25 | -2.8% | -15.9% | ||
| Q4 24 | 8.0% | 3.3% | ||
| Q3 24 | -14.1% | 9.4% | ||
| Q2 24 | 8.4% | -7.3% | ||
| Q1 24 | 24.8% | -9.0% |
| Q4 25 | 0.4% | 0.3% | ||
| Q3 25 | 1.5% | 4.0% | ||
| Q2 25 | 1.5% | 6.8% | ||
| Q1 25 | 0.2% | 7.4% | ||
| Q4 24 | 7.2% | 0.3% | ||
| Q3 24 | 5.6% | 0.0% | ||
| Q2 24 | 3.8% | 0.3% | ||
| Q1 24 | 0.4% | 0.4% |
| Q4 25 | 7.16× | — | ||
| Q3 25 | -1.31× | — | ||
| Q2 25 | 4.85× | — | ||
| Q1 25 | -0.54× | — | ||
| Q4 24 | 11.71× | — | ||
| Q3 24 | -2.10× | — | ||
| Q2 24 | 6.58× | — | ||
| Q1 24 | 4.79× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MAMA
Segment breakdown not available.
SMTI
| Soft Tissue Repair Products | $24.7M | 90% |
| Bone Fusion Products | $2.8M | 10% |
